When it comes to evaluating communications performance, one of the most common questions I hear is: “Why don’t we just analyze everything?” It’s an understandable instinct—especially when “big data” has become synonymous with accuracy. But in reality, more data doesn’t always mean better insight. The key to meaningful measurement isn’t volume; it’s representativeness. That’s where […]
The numbers looked impressive on the surface: 50 million impressions, 500 media placements, and an AVE calculation showing $2.3 million in “earned value.” The client presentation sparkled with charts and graphs. But when the CEO asked the critical question—”How did this impact our business?”—the room went silent. This scenario plays out in conference rooms across […]
You may have noticed more brands stepping into the public arena to discuss their values, their efforts in improving the world or improving the work lives of their employees. This isn’t just your imagination. As far back as 2021, even the Harvard Business Review noted that burgeoning research into corporate social responsibility (CSR) had identified […]
The pharmaceutical business is a complicated, highly regulated business vertical with plenty of complex communications challenges for PR professionals. These challenges – and the opportunities they present – is Fierce Pharma’s annual Pharma PR & Communications Summit West’s raison d’etre. Since its founding in 2021 it’s the only west-coast event focused on communications strategies for […]
A Fullintel mixed-method research paper on trustworthiness and its impact on public and media perception has won the Arthur W. Page Center Benchmarking Award at the International Public Relations Research Conference (IPRRC). The paper, entitled “A Matter of Trust: Understanding the Impact of Trust-Driving Attributes in Three Major American Companies in Media and Public Perceptions,” […]
